Skip to search formSkip to main contentSkip to account menu

PD 176252

Known as: PD-176252, PD176252 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Indoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Structural Determinants in the Binding of BB2 Receptor Ligands: In Silico, X-Ray and NMR Studies in PD176252 Analogues.
BACKGROUND The mammalian bombesin receptor family comprises three G proteincoupled receptors: the neuromedin B receptor, the… 
2016
2016
Phase shifts to light are altered by antagonists to neuropeptide receptors
2015
2015
ML-18 is a non-peptide bombesin receptor subtype-3 antagonist which inhibits lung cancer growth
2012
2012
Expression of gastrin‐releasing peptide is increased by prolonged stretch of human myometrium, and antagonists of its receptor inhibit contractility
•  Increased uterine stretch appears to increase the risk of preterm labour, but the mechanism by which this might occur is… 
2011
2011
Gastrin-Releasing Peptide/Neuromedin B Receptor Antagonists PD176252, PD168368, and Related Analogs Are Potent Agonists of Human Formyl-Peptide Receptors
N-Formyl peptide receptors (FPRs) are G protein-coupled receptors (GPCRs) involved in host defense and sensing cellular… 
2010
2010
Gastrin-releasing peptide promotes the growth of HepG2 cells via EGFR-independent ERK1/2 activation.
Gastrin-releasing peptide (GRP) plays an important role in regulating tumor growth and migration. However, little is known about… 
Highly Cited
2007
Highly Cited
2007
Role of gastrin-releasing peptide and neuromedin B in anxiety and fear-related behavior
Highly Cited
2006
Highly Cited
2006
Bombesin Receptors as a Novel Anti-Anxiety Therapeutic Target: BB1 Receptor Actions on Anxiety through Alterations of Serotonin Activity
The effects of PD 176252 [3-(1H-indol-3-yl)-N-[1-(5-methoxy-pyridin-2-yl)-cyclohexylmethyl]-2-methyl-2-[3-(nitro-phenyl)ureido… 
2003
2003
Nonpeptide gastrin releasing peptide receptor antagonists inhibit the proliferation of lung cancer cells.
1998
1998
PD 176252--the first high affinity non-peptide gastrin-releasing peptide (BB2) receptor antagonist.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)